Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA approves ViiV Healthcare’s Juluca for maintenance treatment of HIV-1 ViiV Healthcare, a joint venture between GlaxoSmithKline (GSK), Pfizer, and Shionogi, has received approval from the U.S. Food… bypharmanewsdailyNovember 25, 2017